Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

METFORMIN HCL 850 MG TABLET

metformin hydrochloride
$0.0248per EA

Strength

850 mg/1

Manufacturer

Mylan Pharmaceuticals Inc.

NDC

00378718605

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

METFORMIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075973

On Market Since

6/3/2010

Pharmacological Classes

Biguanide
Biguanides

Price History

1W

0.0%

1M

+0.4%

3M

+3.8%

6M

+9.8%

1Y

+3.9%

3Y

-8.4%

5Y

-15.9%

All

-35.4%

Generic Alternatives

1 alternative • Same active ingredient

METFORMIN HCL 850 MG TABLET
Generic
23155084210•Heritage Pharmaceuticals Inc.
$0.0248

Related Drugs

Same classification

METFORMIN HCL 500 MG TABLET
Generic
00904716261•Major Pharmaceuticals
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094701•Laurus Labs Limited
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094705•Laurus Labs Limited
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
42385094711•Laurus Labs Limited
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
49483062201•Time-Cap Labs Inc.
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
49483062210•Time-Cap Labs Inc.
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
49483062250•Time-Cap Labs Inc.
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
49483062281•Time-Cap Labs Inc.
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
50228010501•ScieGen Pharmaceuticals Inc.
$0.0139
per EA
METFORMIN HCL 500 MG TABLET
Generic
50228010505•ScieGen Pharmaceuticals Inc.
$0.0139
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy